| Literature DB >> 33992495 |
Jorge Ricoy1, Juan Suárez-Antelo2, José Antúnez3, Anxo Martínez de Alegría4, Lucía Ferreiro5, María Elena Toubes6, Ana Casal7, Luis Valdés8.
Abstract
Pleuroparenchymal fibroelastosis (PPFE) is a rare, generally idiopathic form of interstitial pneumonia with unique clinical, radiological and histopathological features. It is named after the presence of upper lobe pleural and subjacent parenchymal fibrosis, with accompanying elastic fibers. Although it is usually an idiopathic disease, it has been linked to other co-existent diseases. Diagnostic suspicion of PPFE is based on the identification of typical abnormalities on chest CT scan, which are prevailingly located in the upper lobes, adjacent to the apex of the lungs. Diagnosis can be confirmed by histological analysis, although biopsy is not always feasible. The disease is generally progressive, but not uniformly. The course of the disease is frequently slow and involves a progressive loss of upper lobe volume, which results in platythorax, associated with a significant reduction of body mass. PPFE concomitant to other interstitial lung diseases is associated with a poorer prognosis. The disease occasionally progresses rapidly causing irreversible respiratory insufficiency, which leads to death. Currently, there is no effective pharmacological therapy available, and lung transplantation is the best therapeutic option. The purpose of this review is to draw the attention to PPFE, describe its clinical, radiological and histopathological features, analyze its diagnostic criteria, and provide an update on the management of the disease.Entities:
Keywords: Pleuroparenchymal fibroelastosis; Pulmonary upper lobe fibrosis
Mesh:
Year: 2021 PMID: 33992495 DOI: 10.1016/j.rmed.2021.106437
Source DB: PubMed Journal: Respir Med ISSN: 0954-6111 Impact factor: 3.415